-
Prostaglandin E2: From Metabolomics to Assay Design
2026-08-07
Prostaglandin E2 links receptor-level perturbation with tissue-resolved metabolomics and systems pharmacology. This guide shows how PGE2 can improve assay decisions without overstating what complex cardiovascular disease models prove.
-
Redefining CRISPR Precision with Advanced Cas9 mRNA Engineer
2026-08-07
This thought-leadership article presents a mechanistic and strategic perspective on leveraging advanced mRNA engineering for CRISPR-Cas9 genome editing. We integrate biological rationale, recent breakthroughs in mRNA export modulation, and practical workflow guidance, focusing on the unique properties of EZ Cap™ Cas9 mRNA (m1Ψ). By connecting recent peer-reviewed findings with translational research needs, we deliver actionable insights for maximizing editing precision, minimizing off-target effects, and accelerating clinical translation.
-
Dimethyloxalylglycine (DMOG): Protocols and Technical Guidan
2026-08-06
Dimethyloxalylglycine (DMOG) is designed for controlled, reversible stabilization of hypoxia-inducible factors, allowing researchers to mimic hypoxic signaling in vitro and in vivo models. It should only be used in research workflows evaluating oxygen sensing, hypoxia pathways, and inflammation—not for diagnostic or clinical purposes.
-
Light-Inducible RNA Switches for Precision Gene Therapy Cont
2026-08-06
This study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that enables precise, reversible translational control of therapeutic genes in vivo. The approach offers a modular platform for optogenetic regulation, with implications for safer and more adaptable gene and cell-based therapies targeting chronic diseases.
-
TECPR1-Driven Lysosomal Repair During Energy Crisis: Mechani
2026-08-05
The referenced study uncovers a novel mechanism for lysosomal repair under energy stress, demonstrating that TECPR1 mediates membrane tubulation to restore lysosomal integrity. These findings clarify essential pathways for cellular adaptation to metabolic challenges and offer new perspectives for investigating lysosome-related disorders.
-
Sodium Citrate: Molecular Engineering of SERS Substrates
2026-08-05
Explore how sodium citrate enables precision molecular engineering in SERS substrate fabrication. This in-depth analysis reveals unique mechanistic insights and advanced assay considerations beyond standard protocols.
-
Crizotinib Hydrochloride: ALK Kinase Inhibitor in Assembloid
2026-08-04
Crizotinib hydrochloride enables high-fidelity inhibition of ALK and c-Met phosphorylation in patient-derived gastric cancer assembloids, bridging the gap between clinically relevant kinase targeting and the complexities of the tumor microenvironment. This guide details optimized workflows, critical troubleshooting, and actionable parameters for integrating Crizotinib hydrochloride into advanced cancer biology research.
-
ML216: Submicromolar BLM Helicase Inhibitor for DNA Repair R
2026-08-04
ML216, a potent BLM helicase inhibitor from APExBIO, enables precise inhibition of homologous recombination-mediated DNA repair. It demonstrates submicromolar selectivity, robust cellular phenotypes, and critical utility in modeling synthetic lethality in cancer research.
-
FGF-Mediated Apoptotic Resistance via BCL-2 Upregulation
2026-08-03
This study uncovers a non-cell autonomous mechanism where apoptotic stress triggers FGF2 release, activating MEK-ERK signaling and upregulating anti-apoptotic BCL-2 family proteins in neighboring cells. These findings highlight a new layer of complexity in apoptosis regulation, impacting cancer therapy resistance and tissue repair.
-
Macrophage EV-miR-660 Drives Breast Cancer Metastasis via NF
2026-08-03
This study reveals how tumor-associated macrophage-derived extracellular vesicles deliver microRNA-660 to breast cancer cells, suppressing KLHL21 and activating the IKKβ/NF-κB p65 axis to promote metastasis. These mechanistic insights clarify immune-tumor crosstalk and highlight potential intervention points for advanced breast cancer.
-
Dual Luciferase Reporter Gene System: Mechanism & Evidence
2026-08-02
The Dual Luciferase Reporter Gene System is a robust tool for quantifying gene expression regulation with high sensitivity and normalization accuracy. Utilizing distinct firefly and Renilla luciferase enzymes, it enables sequential bioluminescence detection within the same mammalian cell sample. This article details its biological rationale, mechanism, benchmarked performance, and practical workflow parameters.
-
Single-Cell Long-Read Sequencing Reveals RNA Isoform Shifts
2026-08-01
This study pioneers the use of PacBio Kinnex long-read sequencing integrated with single-nucleus transcriptomics to map RNA isoform diversity in Alzheimer’s disease (AD) and control human brain tissue. The approach uncovers extensive, cell-type-specific splicing and novel isoforms, setting a new standard for understanding transcriptomic alterations in neurodegeneration.
-
Benzyl Quinolone Carboxylic Acid: Precision in M1 Receptor R
2026-07-31
Benzyl Quinolone Carboxylic Acid (BQCA) empowers researchers with unmatched selectivity and reproducibility for M1 muscarinic acetylcholine receptor studies. Leveraging advanced protocols and mechanistic insights, BQCA accelerates breakthroughs in cognitive function and Alzheimer’s disease research.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Lab U
2026-07-31
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents unwanted proteolysis during protein extraction and analysis, ensuring integrity for downstream workflows, especially those sensitive to divalent cations. It is not intended for protocols requiring metalloprotease inhibition via EDTA or for applications incompatible with DMSO.
-
SMAD3 Inhibition Reduces ADAMTS-5 in Early Osteoarthritis Mo
2026-07-30
Xiang et al. demonstrate that SMAD3 inhibition, using the selective inhibitor SIS3, downregulates ADAMTS-5 expression in early osteoarthritis both in vitro and in vivo. These findings reveal a regulatory axis involving SMAD3 and miRNA-140, offering new mechanistic insight for osteoarthritis and fibrosis research.